Bio-Rad Laboratories (BIO.B) Stock Chart & Stock Price History $250.08 0.00 (0.00%) As of 06/10/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrendsBuy This Stock Bio-Rad Laboratories Stock Price Performance The Bio-Rad Laboratories (BIO.B) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 13.29%, with a year-to-date return of -23.19%. In the past month, the stock has increased 6.68%, reflecting recent market activity. As of the latest close, Bio-Rad Laboratories traded at $250.08 with a market cap of $7.00 billion and volume of 20 shares. Five years ago, the stock traded at $465.00, representing a 46.22% decrease over that period. At the time, it had a market cap of $13.79 billion and a volume of 100 shares. Receive BIO.B Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Bio-Rad Laboratories and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month Performance+6.68%3 Month Performance-5.92%Year-To-Date Performance-23.19%1 Year Performance-13.29%5 Year Performance-46.22% BIO.B Stock Chart for Thursday, June, 12, 2025 BIO.B Chart by TradingView Bio-Rad Laboratories Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/11/2025$250.08$250.08$250.08$250.0820 shs$7.00 billion06/10/2025$250.08$250.08$250.08$250.0861 shs$7.00 billion06/09/2025$250.08$250.08$250.08$250.0813 shs$7.00 billion06/06/2025$250.08$250.08$250.08$250.0812 shs$7.00 billion06/05/2025$250.08$250.08$250.08$250.0810 shs$7.00 billion06/04/2025$250.08$250.08$250.08$250.0816 shs$7.00 billion06/03/2025$250.08$250.08$250.08$250.082 shs$7.00 billion06/02/2025$250.08$250.08$250.08$250.082 shs$7.00 billion05/30/2025$250.08$250.08$250.08$250.084 shs$7.00 billion05/29/2025$250.08$250.08$250.08$250.084 shs$7.00 billion Get the Latest News and Ratings for BIO.B and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bio-Rad Laboratories and its competitors with MarketBeat's FREE daily newsletter. 05/28/2025$250.08$250.08$250.08$250.089 shs$7.00 billion05/27/2025$250.08$250.08$250.08$250.084 shs$7.00 billion05/26/2025$250.08$250.08$250.08$250.084 shs$7.00 billion05/23/2025$250.08$250.08$250.08$250.083 shs$7.00 billion05/22/2025$250.08$250.08$250.08$250.0811 shs$7.00 billion05/21/2025$250.08$250.08$250.08$250.083 shs$7.00 billion05/20/2025$250.08$250.08$250.08$250.08371 shs$7.00 billion05/19/2025$250.08$250.08$250.08$250.087 shs$7.00 billion05/16/2025$250.08$250.08$250.08$250.085 shs$7.00 billion05/15/2025$250.08$250.08$250.08$250.0831 shs$7.00 billion05/14/2025$250.08$250.08$250.08$250.08275 shs$7.00 billion05/13/2025$234.41$250.08+6.68%$250.08$250.08275 shs$7.00 billion05/12/2025$234.41$234.41$234.41$234.418 shs$6.57 billion Related Companies KEYS Stock Chart VLTO Stock Chart FTV Stock Chart TER Stock Chart RVTY Stock Chart AVTR Stock Chart NVMI Stock Chart VNT Stock Chart MIR Stock Chart ST Stock Chart Receive BIO.B Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Bio-Rad Laboratories and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:BIO.B) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump Makes Major Crypto AnnouncementPay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
